11 Font-Creus B, Bella-Cueto F, Espejo In 1983 Doctors Gharavi and Hughes and I made the decision to set up an anticardiolipin test after it was found that lupus anticoagulant tests performed routinely in our hospital were not sufficiently sensitive and reproducible to identify patients whom we believed to have the lupus anticoagulant syndrome.5 Over the last five years and in the course of working in three very different institutions I remain convinced that our original decision was correct. We have managed to identify a substantial number of patients using the aCL test alone. My most recent experience in Louisville, Kentucky is a case in point. My laboratory has measured aCL levels in about 300 sera and found nine sera with moderate to high positive results. Seven of these sera were from patients with recurrent fetal loss or thrombosis, or both. Despite the fact that these patients had markedly raised IgG or IgM concentrations on several occasions I obtained a positive lupus anticoagulant test result on only two occasions. It is probable that the lupus anticoagulant test performed by the laboratory to which we send our plasma has an insensitive test. In busy outpatient settings in large institutions it is practically impossible for clinicians to meet the technicians performing coagulation tests, much less to have technicians perform the numbers of tests for the lupus anticoagulant outlined by Derksen and colleagues. The requirements that plasma specimens be platelet-poor and be freshly prepared (or stored at -70°C) impose further constraints. In addition, standardisation of the lupus anticoagulant test and measurement of these test results are difficult tasks and are only now being addressed by some international groups, including the KAPS group.
At a time when we are still improving both solid phase antiphospholipid tests and standardising lupus anticoagulant tests sweeping statements such as that made by Derksen and colleagues in the title of their paper are premature. The recent creation of the KAPS group in Jamaica was designed to address some of the issues raised by Derksen and colleagues. Until we know better, wisdom suggests that both tests be performed, if possible. 
